Off to the side perhaps but biotechs back in favour in North America last week. TIS would certainly hit the right spot with any investor seeking exposure to this sector - post P3 and most commercialisation boxes ticked too.
TIS Price at posting:
32.0¢ Sentiment: Buy Disclosure: Held